Manning Napier Profile

USD 0.02  0.15%

Manning Napier Summary

Manning Napier Target 2055 R [MTZRX] is traded in USA and was established on July 23, 2018. The fund is listed under Target-Date 2055 category and is part of Manning & Napier family. Manning Napier Target 2055 R now has accumulated 9.46 M in assets with minimum initial investment of 2 K. , while the total return for the last 3 years was 12.47%.
Check Manning Napier Probability Of Bankruptcy

Instrument Allocation

Sector Allocation (%)

Target Price Odds Analysis

Odds Below 13.4HorizonTargetOdds Above 13.4
76.30%30 days 13.40 23.10%
Based on normal probability distribution, the odds of Manning Napier to move above current price in 30 days from now is about 23.1% (This Manning Napier Target 2055 R probability density function shows the probability of Manning Napier Fund to fall within a particular range of prices over 30 days) .

Manning Napier Target Risk Profiles

Key Fundamentals

Manning Napier Against Markets

Current Ratings

Manning Napier 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Manning Napier Target 2055 R are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
The investment seeks to provide long-term capital growth and to moderate volatility consistent with its current asset allocation. Manning Napier is traded on NASDAQ Stock Exchange in USA. more
NameManning Napier Target 2055 R
Macroaxis Advice
InstrumentUSA Fund View All
Business AddressManning & Napier Fund, Inc
ExchangeNASDAQ Stock Exchange
Fund FamilyManning & Napier
Fund CategoryTarget-Date 2055
Phone800 466 3863
CurrencyUSD - US Dollar

Did you try this?

Run Pair Correlation Now

Pair Correlation

Compare performance and examine historical correlation between any two equity instruments
All  Next Launch Pair Correlation
Please see also Stocks Correlation. Please also try Pair Correlation module to compare performance and examine historical correlation between any two equity instruments.